Labforward has closed a new financing round. The laboratory equipment manufacturers Tecan and 2mag as well as existing investor Peppermint Venture Partners are investing more than € 5 million in the laboratory software company with headquarters in Berlin. Laboratories face the challenge of ... more
New dimension for efficient laboratory work
Laboratory SaaS provider Labforward ramps up Series B financing to >€8.5 million in second closing
With the successful completion of a second closing, Labforward adds >€3m to the Series B from January, bringing the total funds raised to >€8.5m. The majority of the new investment comes from the Fielmann Family Office, majority owner of the leading German family business of the same name that serves its 27m customers across 15 European markets with eyewear and hearing aids.
Labforward has completed a second closing for its Series B. The family office of the Fielmann family, the existing investor IBB Ventures as well as existing and new business angels invest in the laboratory software company with headquarters in Berlin, Germany.
Laboratories have always involved a lot of manual processes that require the presence of an entire laboratory team on site. In the COVID 19 crisis, the degree to which labs have already digitized or automated these processes makes the difference between being able to safely continue important scientific work or having to choose between a complete shutdown or putting employees at risk for several months.
“Last year's experience showed lab teams the importance of investing in automation and digital data management to keep a lab running with fewer on-site staff.” as Dr. Simon Bungers, co-founder and CEO of the company explains: “We’re seeing increased demand for our solutions which let teams control devices remotely, capture data digitally and let scientists access the data in the cloud or an accessible server for analysis and process optimization.”
Innovative digital solutions that improve processes of life science companies, the pharma industry and healthcare in general are at the core of the investment focus of the team behind the Fielmann Family Office. “We are actively searching for software solutions that increase productivity and efficiency in the healthcare industry.” as Peter Stauffer, managing director of the family office explains. He continues: “After experiencing the COVID crisis, no one will accept average drug development cycles of 12 years anymore. Labforward´s manufacturer-independent and device-agnostic offering allows a new dimension for efficient laboratory work and supports the shortening of drug development cycles. We are happy to
invest in the company's growth and to enable the digitization of laboratories around the globe.”
With the additional funding, Labforward is going to invest in further expansion of the team and making the fully-digitized laboratory of the future more accessible to organizations that look for smart solutions for their laboratories. “Together with partners from the industry, we are currently building a showroom laboratory in Berlin. There, laboratory teams from around the world can experience what is possible with the technology of today. It’s going to be a great place to demonstrate how connected laboratories work and it also allows us to test a lot of ideas and innovations.” Simon Bungers explains.
The showroom is going to be opened in summer of this year.
labfolder GmbH, a electronic laboratory notebook (ELN, Electronic Lab Notebook) provider, and cubuslab GmbH, a provider of a manufacturer-independent platform for the digital integration of laboratory instruments, today announced their merger. The joint company will operate under the name L ... more
- 1Smartphone-powered microchip for at-home medical diagnostic testing developed
- 2Endress+Hauser bundles analysis expertise
- 3Measuring the ‘wettability’ of graphene and other 2D materials
- 4analytica 2022: Analytics that benefit consumer and environmental protection
- 5New technique shows in detail where drug molecules hit their targets in the body
- 6Why are neuron axons long and spindly?
- 7Seeing more deeply into nanomaterials
- 8Bruker and TOFWERK Form Strategic Partnership
- 9Researchers demonstrate label-free super-resolution microscopy
- 10A sharper image for proteins
- A successful first half year for ZEISS
- Eppendorf increases 2021 revenue to €1.1 billion
- Sartorius records dynamic start to the new fiscal year
- Pioneers in observing single molecules in living cells closes $75 million Se ...
- OxDX raises £2.6M pre-seed funding to develop AI powered rapid diagnostic te ...